XRAY - DENTSPLY SIRONA Inc.
| Previous Close | 54.62 |
| Open | 54.28 |
| Bid | 53.63 x 1200 |
| Ask | 53.69 x 800 |
| Day's Range | 52.46 - 54.35 |
| 52 Week Range | 33.93 - 55.88 |
| Volume | 502,032 |
| Avg. Volume | 1,785,891 |
| Market Cap | 12.506B |
| Beta (3Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.72 |
| Earnings Date | Aug 5, 2019 - Aug 9, 2019 |
| Forward Dividend & Yield | 0.35 (0.68%) |
| Ex-Dividend Date | 2019-06-27 |
| 1y Target Est | 58.08 |
- Zacks•1 hour ago
Veeva Systems (VEEV) to Report Q1 Earnings: What's in Store?
Top-line growth and solid show by Subscription services and Professional services units are likely to aid Veeva Systems (VEEV) in Q1 earnings. However, rising expenses remains a dampener.
- Zacks•1 hour ago
Medtronic (MDT) Q4 Earnings Beat, Operating Margin Rises
Excluding the Diabetes group, Medtronic (MDT) displays better performances at CER on the back of growth in rest of the business segments and across all geographies.
- Zacks•2 hours ago
Here's Why You Should Hold On to Integra LifeSciences Stock
Investor confidence is still high on growth prospects of Integra LifeSciences (IART).
- GlobeNewswire•2 hours ago
Dentsply Sirona to Present at the Stifel 2019 Dental & Veterinary Conference on May 29th
Nick Alexos, CFO, will represent the company and is scheduled to present at 3:00 PM ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting www.dentsplysirona.com. A replay of the presentation will also be available on the Dentsply Sirona website at www.dentsplysirona.com.
- Zacks•3 hours ago
QIAGEN (QGEN) to Win U. N. Accolade for QuantiFERON-TB Access
This acclaim marks a giant leap for QIAGEN (QGEN) in the field of tuberculosis diagnosis.
- Zacks•3 hours ago
AngioDynamics IDE Application for NanoKnife Gets FDA Nod
AngioDynamics' (ANGO) pilot study is intended to support the approval of a future PMA in the United States.
- GlobeNewswire•4 hours ago
Dentsply Sirona Board Approves Relocation of Headquarters to Charlotte N.C. and Announces CFO Transition Plan
CHARLOTTE, N.C., May 23, 2019 -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that the Board of Directors approved the.
- GlobeNewswire•18 hours ago
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., May 22, 2019 -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a.
- Zacks•yesterday
Hologic Breast Health Arm Aids Strongly, Rising Costs Ail
Within Breast Health, Hologic (HOLX) unveils a string of products including 3Dimensions and 3D Performance gantries, Clarity HD, SmartCurve, Affirm prone biopsy system and Brevera biopsy system.
- Zacks•yesterday
Will RTG Again Bolster Medtronic's (MDT) Earnings in Q4?
Within Neurovascular, we hope to witness strength across Medtronic's (MDT) stroke franchise with growth in stent retrievers, flow diverters, neuro access and embolic products.
- Zacks•yesterday
ResMed Study Shows Remote Monitoring Benefits on CPAP Use
Results of this study mark a remarkable feat for ResMed's (RMD) medical innovation aimed at treating people suffering from sleep apnea.
- Zacks•yesterday
Here's Why You Should Buy Masimo (MASI) Stock Right Now
Masimo (MASI) benefits from launches like Halo ION.
- Zacks•2 days ago
Avedro (AVDR) Hits a 52-Week High on Solid Growth Prospects
Avedro (AVDR) gains from promising developments in recent times.
- Zacks•2 days ago
Varian Medical's CTSI Buyout to Boost Oncology Services Unit
The CTSI buyout is expected to prove accretive to Varian Medical's (VAR) adjusted earnings per share during fiscal 2021.
- Zacks•2 days ago
Why Should You Hold on to Myriad Genetics (MYGN) Stock?
Investor confidence is still high on growth prospects of Myriad Genetics (MYGN).
- Zacks•3 days ago
LabCorp Grows on Strong Diagnostics Arm Amid Contract Losses
LabCorp's (LH) diagnostics business grows organically despite additional price reductions.
- Zacks•3 days ago
Medtronic (MDT) Launches Telescope Guide Extension Catheter
The launch of Telescope marks Medtronic's (MDT) foray into the guide extension catheter market.
- Zacks•3 days ago
ABIOMED (ABMD) to Launch Impella CP With SmartAssist at SCAI
ABIOMED's (ABMD) Impella CP receives Japanese PMDA approval in recent times.
- Zacks•6 days ago
Here's Why You Should Hold on to Tandem (TNDM) Stock for Now
Investor confidence in Tandem Diabetes (TNDM) is still high on several positive factors.
- Zacks•6 days ago
Varian Medical Installs ProBeam at Research Hub in Singapore
Varian Medical's (VAR) APAC revenues grow 7% year over year in the fiscal second quarter.
- Zacks•8 days ago
Integra LifeSciences Rides on Product Launch, Faces Rivalry
Benefiting from new products and an improved sales force performance, Integra LifeSciences (IART) projects speedy organic growth in the second half of 2019.
- Zacks•9 days ago
STERIS (STE) Q4 Earnings Surpass Estimates, Margins Rise
STERIS (STE) witnesses solid revenue growth across each of its operating segments in the reported quarter.
- Zacks•9 days ago
Medtronic to Acquire Titan Spine for Spine Portfolio Boost
According to Medtronic (MDT), interbody implants material and shape play a vital role in the bone growth process during fusions and presently, titanium interbody devices are rapidly becoming popular.
- Zacks•9 days ago
ABIOMED's Impella 5.0 and LD Receive Expanded FDA Approvals
ABIOMED's (ABMD) FDA-approved Impella 2.5 and Impella CP treat certain advanced heart failure patients.
- Zacks•10 days ago
Abbott Rides on Strong CGM, Poor Rhythm Management Ails
Abbott (ABT) is attracting constant attention with developments in its flagship, sensor-based continuous glucose monitoring (CGM) system called FreeStyle Libre System.
